Stock Events

Stock Events

Tandem Diabetes Care 

$19.90
80
-$0.53-2.59% 20:00 Today
+$0.29+1.46%22:49After hours

Statistics

Day High
20.36
Day Low
19.49
52W High
29.65
52W Low
11.46
Volume
1,363,471
Avg. Volume
1,977,920
Mkt Cap
1.38B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

4NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.67
-0.45
-0.23
-0.01
Expected EPS
-0.243811
Actual EPS
N/A

Financials

-20.17%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
1.01BRevenue
-204.71MNet Income

Analyst Ratings

27.04Average Price Target
The highest estimate is 55.00.
From 14 ratings within the last 6 months. This is not an investment recommendation.
Buy
50%
Hold
50%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow TNDM. It's not an investment recommendation.
Microsoft
15
MSFT
Tesla
15
TSLA
Amazon
13
AMZN
AMD
12
AMD

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Dexcom
DXCM
Mkt Cap34.27B
Dexcom produces continuous glucose monitoring systems, directly competing in the diabetes management space with Tandem's insulin pumps.
Insulet
PODD
Mkt Cap10.07B
Insulet Corporation offers the Omnipod, an insulin management system that competes with Tandem's insulin pump products.
Medtronic
MDT
Mkt Cap116.77B
Medtronic is a major player in the diabetes care market, offering insulin pumps and continuous glucose monitoring systems that compete with Tandem's offerings.
Abbott Laboratories
ABT
Mkt Cap194.62B
Abbott Laboratories produces the FreeStyle Libre, a continuous glucose monitoring system, competing in the broader diabetes management market.
Senseonics
SENS
Mkt Cap493.31M
Senseonics Holdings offers the Eversense CGM system, a direct competitor in the continuous glucose monitoring market.
Thermo Fisher Scientific
TMO
Mkt Cap230.05B
Thermo Fisher Scientific, through its life sciences solutions, indirectly competes in the diabetes care market by providing technologies and supplies that support diabetes research and diagnostics.
Novo Nordisk
NVO
Mkt Cap201.64B
Novo Nordisk is a leading global healthcare company that, while primarily known for its diabetes medications, also invests in diabetes care devices and solutions, positioning it as a broader competitor.
Sanofi
SNY
Mkt Cap107.39B
Sanofi is involved in diabetes care through its insulin and glucose monitoring solutions, making it a competitor in the diabetes management space.
Baxter International
BAX
Mkt Cap13.51B
Baxter International offers medical devices that, while not directly competing in the insulin pump or CGM markets, provide various healthcare solutions that can be used in diabetes care.
Johnson & Johnson
JNJ
Mkt Cap645.95B
Johnson & Johnson, through its medical devices and pharmaceutical segments, has interests in the diabetes market, making it a broader competitor in the healthcare space for diabetes management.

About

Tandem Diabetes designs, manufactures, and markets durable insulin pumps for individuals with diabetes. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on the Sigi tubeless patch pump. Tandem is also developing a fully closed-loop algorithm for its pumps. Nearly three-quarters of total revenue is derived from the US, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one-third is from disposable infusion sets that need to be changed over every 3 to 7 days.
Show more...
CEO
John F. Sheridan
Employees
2500
Country
United States
ISIN
US8753722037
WKN
000A2H5BX

Listings

XNAS
US
TNDM
STU
DE
TD5A.STU
LSE
GB
0M0F.LSE
MU
DE
TD5A.MU

0 Comments

Share your thoughts

FAQ

What is Tandem Diabetes Care stock price today?▼
The current price of TNDM is $19.90 USD — it has decreased by -2.59% in the past 24 hours. Watch Tandem Diabetes Care stock price performance more closely on the chart.
What is Tandem Diabetes Care stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Tandem Diabetes Care stocks are traded under the ticker TNDM.
Is Tandem Diabetes Care stock price growing?▼
TNDM stock has fallen by -7.14% compared to the previous week, the month change is a -1.49% fall, over the last year Tandem Diabetes Care has showed a +60.61% increase.
What is Tandem Diabetes Care market cap?▼
Today Tandem Diabetes Care has the market capitalization of 1.38B
When is the next Tandem Diabetes Care earnings date?▼
Tandem Diabetes Care is going to release the next earnings report on November 04, 2026.
What were Tandem Diabetes Care earnings last quarter?▼
TNDM earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.32 USD resulting in a +4.37% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Tandem Diabetes Care revenue for the last year?▼
Tandem Diabetes Care revenue for the last year amounts to 1.01B USD.
What is Tandem Diabetes Care net income for the last year?▼
TNDM net income for the last year is -204.71M USD.
How many employees does Tandem Diabetes Care have?▼
As of September 04, 2026, the company has 2,500 employees.
In which sector is Tandem Diabetes Care located?▼
Tandem Diabetes Care operates in the Health & Wellness sector.
When did Tandem Diabetes Care complete a stock split?▼
The last stock split for Tandem Diabetes Care was on October 10, 2017 with a ratio of 1:10.
Where is Tandem Diabetes Care headquartered?▼
Tandem Diabetes Care is headquartered in San Diego, United States.